Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas

Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study analyzed the efficacy and toxicity of temozolomide in 25 adult patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Seung-Ho, Kim, Moon-Kyu, Lee, Tae-Kyu, Lee, Kwan-Sung, Jeun, Sin-Soo, Park, Chun-Kun, Kang, Joon-Ki, Kim, Moon-Chan, Hong, Yong-Kil
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729901/
https://www.ncbi.nlm.nih.gov/pubmed/16891823
http://dx.doi.org/10.3346/jkms.2006.21.4.739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729901/
https://www.ncbi.nlm.nih.gov/pubmed/16891823
http://dx.doi.org/10.3346/jkms.2006.21.4.739

Ejemplares similares